Krystal Biotech Inc —— 财务报表 (NASDAQ:KRYS) | MetaTrader

展开完整图表

新闻

OCGN Gene-Agnostic Eye Therapy Could Shift Retinal Drug Development

Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Data

OCGN Gene Therapy Pipeline: 2026-2027 Catalysts To Watch

Why Is Krystal Biotech (KRYS) Down 11.5% Since Last Earnings Report?

Krystal Biotech总裁Krishnan Krish S出售价值658万美元的KRYS股票

Krishnan Krish S, president of Krystal Biotech, sells $6.58 million in KRYS stock

Krystal Biotech董事Krishnan出售价值658万美元股票

Krystal Biotech director Krishnan sells $6.58 million in shares

Krystal Biotech在TD Cowen会议上:战略增长与挑战

Krystal Biotech at TD Cowen Conference: Strategic Growth and Challenges

Krystal Biotech董事Daniel Janney出售价值325万美元股票

Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million